DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts DMAC Hot Sheet
Join SI Premium – FREE
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q1 EPS of ($0.19), in-line with the analyst estimate of ($0.19).
For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing
- Matinas BioPharma gets NYSE American compliance notice
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
